BAIAP2

BAR/IMD domain containing adaptor protein 2, the group of I-BAR domain containing

Basic information

Region (hg38): 17:81035122-81117434

Links

ENSG00000175866NCBI:10458OMIM:605475HGNC:947Uniprot:Q9UQB8AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the BAIAP2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the BAIAP2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
3
clinvar
7
clinvar
10
missense
27
clinvar
2
clinvar
29
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
4
clinvar
1
clinvar
1
clinvar
6
Total 0 0 31 6 8

Variants in BAIAP2

This is a list of pathogenic ClinVar variants found in the BAIAP2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
17-81035301-T-A not specified Uncertain significance (Jun 06, 2023)2557754
17-81035353-T-C Attention deficit hyperactivity disorder Uncertain significance (-)2507410
17-81084849-A-G not specified Uncertain significance (Apr 22, 2024)3260297
17-81084874-A-G not specified Uncertain significance (Oct 05, 2023)3132859
17-81085704-G-T not specified Uncertain significance (Jan 23, 2023)2461800
17-81086480-A-G not specified Uncertain significance (Dec 28, 2023)3132860
17-81086553-T-A Benign (Apr 26, 2018)735383
17-81098211-A-G Attention deficit hyperactivity disorder Uncertain significance (-)2507408
17-81099957-C-T Likely benign (Apr 10, 2018)735929
17-81099973-G-T not specified Uncertain significance (May 20, 2024)3260301
17-81099993-C-T Benign (Aug 08, 2018)778754
17-81100050-G-A Benign (Dec 31, 2019)711694
17-81100062-C-T Benign (Mar 30, 2018)736258
17-81103493-C-T Benign (Dec 31, 2019)720773
17-81103530-C-T not specified Uncertain significance (Jan 04, 2022)2352170
17-81103578-C-T not specified Uncertain significance (Nov 03, 2023)3132861
17-81103610-G-A not specified Uncertain significance (Sep 14, 2021)3132862
17-81103613-G-A not specified Uncertain significance (Aug 02, 2021)2355154
17-81103931-C-A not specified Uncertain significance (Aug 02, 2021)2386124
17-81103942-C-T Likely benign (Jan 19, 2018)734861
17-81103944-G-A not specified Uncertain significance (May 14, 2024)3260300
17-81103946-G-A not specified Uncertain significance (Jul 06, 2021)2206750
17-81103971-A-G not specified Uncertain significance (Feb 27, 2023)2489188
17-81103976-C-T not specified Uncertain significance (Jan 23, 2024)3132863
17-81104016-C-G not specified Uncertain significance (Oct 10, 2023)3132864

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
BAIAP2protein_codingprotein_codingENST00000321300 1582285
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.4620.5381257340121257460.0000477
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense2.062493590.6940.00002383602
Missense in Polyphen54128.610.419891323
Synonymous-3.412191641.340.00001301058
Loss of Function3.81627.60.2170.00000117329

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002890.0000289
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00004640.0000462
European (Non-Finnish)0.00007160.0000703
Middle Eastern0.000.00
South Asian0.000.00
Other0.0003280.000326

dbNSFP

Source: dbNSFP

Function
FUNCTION: Adapter protein that links membrane-bound small G- proteins to cytoplasmic effector proteins. Necessary for CDC42- mediated reorganization of the actin cytoskeleton and for RAC1- mediated membrane ruffling. Involved in the regulation of the actin cytoskeleton by WASF family members and the Arp2/3 complex. Plays a role in neurite growth. Acts syngeristically with ENAH to promote filipodia formation. Plays a role in the reorganization of the actin cytoskeleton in response to bacterial infection. Participates in actin bundling when associated with EPS8, promoting filopodial protrusions. {ECO:0000269|PubMed:11130076, ECO:0000269|PubMed:11696321, ECO:0000269|PubMed:14752106, ECO:0000269|PubMed:17115031, ECO:0000269|PubMed:19366662}.;
Pathway
Adherens junction - Homo sapiens (human);Regulation of actin cytoskeleton - Homo sapiens (human);Regulation of Actin Cytoskeleton;Signal Transduction;VEGFA-VEGFR2 Pathway;Fcgamma receptor (FCGR) dependent phagocytosis;Innate Immune System;Immune System;RHO GTPases Activate WASPs and WAVEs;RHO GTPase Effectors;Signaling by Rho GTPases;EGFR1;ErbB1 downstream signaling;Regulation of actin dynamics for phagocytic cup formation;Signaling by VEGF;Signaling by Receptor Tyrosine Kinases;RAC1 signaling pathway;CDC42 signaling events;PDGFR-beta signaling pathway (Consensus)

Recessive Scores

pRec
0.160

Intolerance Scores

loftool
0.423
rvis_EVS
-1.4
rvis_percentile_EVS
4.22

Haploinsufficiency Scores

pHI
0.143
hipred
Y
hipred_score
0.745
ghis
0.649

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.908

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Baiap2
Phenotype
homeostasis/metabolism phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
plasma membrane organization;axonogenesis;brain development;insulin receptor signaling pathway;regulation of cell shape;response to bacterium;dendrite development;positive regulation of actin filament polymerization;regulation of actin cytoskeleton organization;protein localization to synapse;Fc-gamma receptor signaling pathway involved in phagocytosis;vascular endothelial growth factor receptor signaling pathway;regulation of synaptic plasticity;actin filament bundle assembly;actin crosslink formation;positive regulation of dendritic spine morphogenesis;cellular response to epidermal growth factor stimulus;cell-cell adhesion;modification of synaptic structure, modulating synaptic transmission;cellular response to L-glutamate;regulation of modification of postsynaptic actin cytoskeleton;positive regulation of actin cytoskeleton reorganization;positive regulation of excitatory postsynaptic potential
Cellular component
ruffle;nucleoplasm;cytoplasm;rough endoplasmic reticulum;Golgi apparatus;cytosol;microtubule;plasma membrane;cell-cell adherens junction;actin cytoskeleton;secretory granule;filopodium;neuronal cell body;dendritic shaft;neuron projection terminus;excitatory synapse;neuron projection branch point;dendritic spine cytoplasm;extracellular exosome;synaptic membrane;Schaffer collateral - CA1 synapse;glutamatergic synapse;postsynaptic density, intracellular component;presynaptic cytosol;postsynaptic cytosol
Molecular function
transcription cofactor binding;protein binding;protein C-terminus binding;cytoskeletal adaptor activity;PDZ domain binding;identical protein binding;proline-rich region binding;scaffold protein binding;cadherin binding involved in cell-cell adhesion